This is the authors' abstract. We don't add key points for this paper.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of betahistine in patients with either Ménière's disease or Ménière's syndrome.
No takes yet. Share an insight, caveat, or question.
Esch et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: